California Resources Corp (CRC)

California Resources Corporation Schedules Third Quarter 2026 Earnings Conference Call

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

Head to Head Comparison: California Resources (NYSE:CRC) versus Kinetik (NYSE:KNTK)

Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition

California Resources to Divest Uinta Basin Assets for $90 Million

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

California Resources Corporation Announces Divestiture of Uinta Basin Assets

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu

Why Is California Resources (CRC) Up 2.7% Since Last Earnings Report?

California Resources Completes $63M Acquisition of Crimson Midstream

California Resources Corporation Completes Acquisition of Crimson

Driving California's Energy Future: California Resources Corporation Releases 2025 Sustainability Update

Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology

CRC Down 14.1% in 3 Months: Can Cost Gains Turn It Around?

Is CRC Stock Worth Buying Despite Its Premium Valuation?

Can CRC's $63M Crimson Deal Ease California Constraints?

CRC Q2 Earnings Miss on Takeaway Constraints, Revenues Beat

California Resources Corporation $CRC Shares Purchased by Bank of America Corp DE